Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women-Reference-Cited by-同舟云学术

Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women

Published:2003-10 Issue:10 Volume:18 Page:854-863
ISSN:0884-8734
Container-title:Journal of General Internal Medicine
language:en
Short-container-title:J Gen Intern Med

Author:

Kim Catherine,Hofer Timothy P.,Kerr Eve A.

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.springerlink.com/index/pdf/10.1046/j.1525-1497.2003.20910.x

Reference133 articles.

1. American Heart Association. American Heart Association 2002 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 2001:1–38.

2. Miettinen T, Pyorala K, Olsson A, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Circulation. 1997;96:4211–8.

3. McPherson R, Genest J, Angus C, Murray P. The Women’s Atorvastatin Trial on Cholesterol (WATCH): frequency of achieving NCEP-II target LDL-C levels in women with and without established CVD. Am Heart J. 2001;141:949–56.

4. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339:1349–57.

5. Lewis S, Sacks F, Mitchell J, et al. Effect of pravastatin on cardiovascular events in women after myocardial infarction. The Cholesterol and Recurrent Events (CARE) trial. J Am Coll Cardiol. 1998;32:140–6.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender disparities in patient education provided during patient visits with a diagnosis of coronary heart disease;Women's Health;2019-01

2. Koronare Herzerkrankung – Unterschiede in Symptomatik und Verlauf bei Männern und Frauen;DMW - Deutsche Medizinische Wochenschrift;2017-10

3. Patient, Physician, and Practice Characteristics Associated with Cardiovascular Disease Preventive Care for Women;Journal of Women's Health;2017-05

4. Hyperlipidemia and Medical Expenditures by Cardiovascular Disease Status in US Adults;Medical Care;2017-01

5. Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population;Journal of Women's Health;2016-07